Table 2.

Overview of participants characteristics.^a,^b,^c

Study	Group	Sample Size	Females	Mean Age (SD)	Months Since Stroke (SD) d	Left Paretic Side
Hoyer et al, 201225	ExG	30	12	52 (10)	3.2 (1.4)B	17
	CG	30	10	52 (13)	3.3 (1.3)B	17
Globas et al, 201222	ExG	20	4	69 (7)	60.2 (46.6)c	14
	CG	18	3	69 (6)	70 (67.4)c	9
Kuys et al, 201123	ExG	15	8	63 (14)	1.7 (1.1)A	5
	CG	15	10	72 (17)	1.6 (1.0)A	9
Duncan et al, 201126	ExG	139	54	60 (12)	2.1 (0.3)B	63
	ExG	143	69	63 (13)	6 (NA)C	58
	CG	126	61	63 (13)	2.1 (0.3)B	61
Langhammer et al, 201024	ExG	21	11	74 (13)	14 (34.5)C	6
	CG	18	12	75 (10)	11.6 (27.3)C	5
Dean et al, 201027	ExG	64	26	70 (9)	0.6 (0.3)A	34
	CG	62	29	71 (9)	0.6 (0.2)A	36
Luft et al, 200813	ExG	37	18	63 (9)	62.5 (NA)C	21
	CG	34	20	64 (10)	44.6 (NA)C	12
Macko et al, 200514	ExG	32	10	63 (10)	35 (29)C	14
	CG	29	8	64 (8)	39 (59)C	16
Suputtitada et al, 200415	ExG	24	4	61 (10)	27.33 (26.6)C	9
	CG	24	9	65 (11)	21.67 (27.7)C	8
Ada et al, 200316	ExG	13	4	66 (11)	28 (17)C	5
	CG	14	4	66 (11)	26 (20)C	8
Pohl et al, 200217	ExG	20	4	59 (11)	4.05 (4.1)B	5
	ExG	20	6	57 (14)	4.2 (5.1)B	4
	CG	20	7	62 (11)	4 (4.5)B	4
da Cunha et al, 200218	ExG	7	0	58 (6)	0.5 (0.3)A	0
	CG	8	0	59 (13)	0.6 (0.4)A	4
Nilsson et al, 200119	ExG	36	6	54†	0.7† A	11
	CG	37	6	56†	0.6† A	14
Laufer et al, 200120	ExG	15	6	67 (7)	1.1 (0.7)A	5
	CG	14	5	69 (8)	1.2 (0.6)A	5
Kosak and Reding, 200021	ExG	22	9	74 (2)	1.3 (0.1)A	8
	CG	34	16	70 (2)	1.3 (0.1)A	12

Abbreviations: ExG, SD, standard deviation; ExG, experimental group; CG, control group; NA, not available.

^aThe symbol † denotes median.

^bThe superscripts ^A,^B, and ^C denotes the acute (n = 6). subacute (n = 3), and chronic (n = 6) stage poststroke, respectively.

^cRows in boldface denote studies that used body weight support treadmill training (n = 7).

^dThe months since stroke column denotes the period between stroke onset and the beginning of the intervention.